CV Sciences Earnings Estimate

CV Sciences Earnings per Share Projection vs Actual

About CV Sciences Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of CV Sciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current CV Sciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as CV Sciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
CV Sciences, Inc. operates as a life science company in North America. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California. Cv Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 69 people.

Currently Active Assets on Macroaxis

Other Information on Investing in CVSI OTC Stock

CV Sciences financial ratios help investors to determine whether CVSI OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVSI with respect to the benefits of owning CV Sciences security.